Drug Shortage Report for TARO-BUDESONIDE
| Report ID | 173508 |
| Drug Identification Number | 02494272 |
| Brand name | TARO-BUDESONIDE |
| Common or Proper name | BUDESONIDE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.25MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION |
| Packaging size | 2 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-03-15 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2023-02-01 | French | Compare |
| v17 | 2023-02-01 | English | Compare |
| v16 | 2023-01-19 | French | Compare |
| v15 | 2023-01-19 | English | Compare |
| v14 | 2023-01-10 | French | Compare |
| v13 | 2023-01-10 | English | Compare |
| v12 | 2023-01-10 | French | Compare |
| v11 | 2023-01-10 | English | Compare |
| v10 | 2022-12-19 | French | Compare |
| v9 | 2022-12-19 | English | Compare |
| v8 | 2022-12-12 | French | Compare |
| v7 | 2022-12-12 | English | Compare |
| v6 | 2022-11-24 | French | Compare |
| v5 | 2022-11-24 | English | Compare |
| v4 | 2022-11-15 | French | Compare |
| v3 | 2022-11-15 | English | Compare |
| v2 | 2022-11-03 | French | Compare |
| v1 | 2022-11-03 | English | Compare |